openPR Logo
Press release

Lupus Nephritis Market - Worldwide Industry Volume And Region Analysis - 2023

06-19-2017 02:58 PM CET | Health & Medicine

Press release from: Transparency Market Research

Lupus Nephritis Market - Worldwide Industry Volume And Region

Global Lupus Nephritis Market

Lupus nephritis refers to the kidney damage caused by the disease lupus erythematosus. Lupus erythematosus is an autoimmune disease where the immune system turns against the body, affecting vital organs. Systemic lupus erythematosus affects the kidneys, joints, skin, and brain and can be fatal. While the primary cause of the disease is unknown, it is expected that factors such as viruses, infections, pollutants, and toxic chemicals, along with family history plays a role in causing the disease. The disease is more common in women compared to men.

Obtain Report Details @ http://www.transparencymarketresearch.com/lupus-nephritis-market.html

Kidney damage from lupus erythematosus can vary from mild to severe. In lupus nephritis, glomeruli or the filtering units are damaged. As a result, waste from the blood does not get filtered. A majority of the patients diagnosed with lupus erythematosus suffer from some kidney damage. The key symptoms of lupus nephritis are flank pain, dark urine, weight gain due to retention of extra fluid, swelling of hands, feet, eyes, and high blood pressure.

Global Lupus Nephritis Market: Overview

The growing prevalence of lupus nephritis and awareness among patients have propelled the growth of the global lupus nephritis market. Rise in number of clinical trials conducted by key market players and the launch of new biologic drugs will also augment the growth of the global lupus nephritis market. However, prolonged regulatory processes regarding the approval of biologic drugs are likely to hamper the market’s growth in the near future.

To diagnose lupus nephritis, tests such as blood tests, urine tests, and imaging tests, including biopsy and ultrasound, are commonly conducted. There are five different types of lupus nephritis and the treatment depends upon the disease type. Biopsy is the only way to determine the type of lupus nephritis.

Medications used in the treatment of lupus nephritis include immunosuppressive drugs, corticosteroids, and drugs to prevent blood clots and low blood pressure. Corticosteroids are strong anti-inflammatory drugs that are prescribed to improve inflammations caused by lupus nephritis. Immunosuppressive drugs such as azathioprine, cyclophosphamide, and mycophenolate suppress the immune system activity that affects the kidneys. A newer medication, belimumab, is a monoclonal antibody and is prescribed as a biologic drug for the treatment of the disease. Antimalarial drugs are also used to help control the disease. Dialysis and kidney transplant are ultimately prescribed for patients suffering from loss of kidney function even with intake of drugs.

Global Lupus Nephritis Market: Region-wise Outlook

The global lupus nephritis market has been segmented into four key regions: North America, Asia Pacific, Europe, and Rest of the World. Robust healthcare infrastructure and research and development activities in developed economies in North America and Europe have propelled the growth of the lupus nephritis market in these regions. The growing prevalence of the disease in North America has also augmented the market growth. It is estimated that about 1.5 million Americans suffer from lupus. In Asia Pacific, the market has registered significant demand with the introduction of biologics.

Fill The Form To Gain Deeper Insights On This Market @ http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=10856

Some of the key players in the global lupus nephritis market are Roche, Merck, Bristol-Myers Squibb, Eli Lilly, and GlaxoSmithKline. The key market players are focusing on the development of biologic drugs. Benlysta, developed by GlaxoSmithKline, is the only approved biologic drug in the global lupus nephritis market.

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lupus Nephritis Market - Worldwide Industry Volume And Region Analysis - 2023 here

News-ID: 585329 • Views: 154

More Releases from Transparency Market Research

Pre-Printed Paper Rolls Market Demand Analysis and Projected huge Growth by 2027
Pre-printed paper rolls can be a powerful marketing tool for any business. In addition to these pre-printed paper rolls can be used for several applications such as labels, tapes, QR codes, etc. Pre-printed paper rolls are cost-effective and form a brand impression on consumers. Pre-printed paper rolls can be printed in many colors. They are colorful and appealing and are not like ordinary papers. For More Detailed Analysis, Request PDF
Duffle Top Bulk Bags Market Generates Huge Revenue Till 2027- Study By Key Playe …
Duffle top bulk bags made from plastic last long and are highly durable. Duffle top bulk bags are flexible and are strong to carry heavy loads. They have lift straps fixed at the top of the bag, which helps in handling and movement of duffle top bulk bags. Duffle top bulk bags can be of various types, which include opening from the bottom or opening from top. They are lightweight
Multi-Dose Packaging System Market Demand & Future Scope Including Top Players
Medicinal wastage and error in taking proper medication lead to need for multi-dose packaging system. Multi-dose packaging system has various benefits, which includes assisting patients with complicated prescription routines and the ability to enhance patient safety. It provides high-quality, smart packaging and also provides convenience to the patients. Multi-dose packaging system provides consumers with product protection, quality, and patient comfort. It has normal handling, and the formulation present in the
Cargo Belt Market 2020 Growth Rate, Developments in Major Areas, Market Size, Dy …
Globalization leads to the need for transportation of goods over the longer distance. This will drive the demand for cargo belts in the logistics & transportation industry. During the transportation of goods, about one-fourth of the accidents occurred due to poor handling of goods, which can be avoided by using the cargo belt. They are used in light and heavy lorries, trailers trucks, ships, and air crafts. Request PDF Sample For

All 5 Releases


More Releases for Lupus

Global Systemic Lupus Erythematosus and Lupus Nephritis Drugs Market US$ 1.8 Bil …
The global systemic lupus erythematosus and lupus nephritis drugs market expected to reach US$ 1.8 billion by 2021, growing at CAGR 7.4% over the forecast period 2017-2021. Systemic lupus erythematosus (SLE) is a prototypic autoimmune disease that is characterized by systemic chronic inflammation that can affect multiple major organ systems. A major contributor to morbidity and mortality among patients with SLE is renal involvement, known as lupus nephritis (LN). Visit The
Systemic Lupus Erythematosus and Lupus Nephritis Market - Global Drug Forecast a …
Latest industry research report on: Systemic Lupus Erythematosus and Lupus Nephritis Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple major organ systems in the
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
Recent research and the current scenario as well as future market potential of "PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 " globally. Summary Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune disease that can affect any organ or tissue and is the prototypic autoimmune disease. As a multisystem disorder, SLE is heterogeneous in nature-no two cases of lupus are alike-and can affect multiple
Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) …
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) Global Clinical Trials Review, H2, 2014”. This report provides data on the Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Chronic Cutaneous Lupus Erythematosus (CCLE)
PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Fore …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz" View Full Report : https://www.marketresearchreports.biz/reports/1045237/pharmapoint-systemic-lupus-erythematosus-and-market-research-reports Systemic lupus erythematosus (SLE) is a systemic inflammatory autoimmune
Lupus Erythematosus Market -API Insights, 2017
Summary Orbis Research Present “Lupus Erythematosus-API Insights, 2017” Description The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage